Evicenter
P&T meetings

Ulixacaltamide

Essential tremor

Regulatory submission
NDA submitted by February 2026
Launch
Not announced
Last updated
78 sources

Product information and disease descriptionPlace of product in therapyDisease description

Clinical presentation - signs and symptoms

2 evidence topics · 2 sources

Motor symptoms: upper limb tremor and additional affected regions

“ET is characterized by involuntary rhythmic movement in the upper limbs” (opens the source at this quote in a new tab)

“head, vocal cords, or legs.” (opens the source at this quote in a new tab)

Nonmotor symptoms: cognition, mood, balance, and sleep

“poorer balance, cognitive impairment, depression and sleep dysregulation.” (opens the source at this quote in a new tab)